Hépatite C

Hepatitis C

Hepatitis C is a viral infection primarily transmitted through blood. Screening for the disease is crucial to ensuring that infected individuals receive the treatments that can now lead to a cure.

Our missions

  • Monitoring the epidemiological trends of hepatitis C

  • Enabling the adaptation of preventive measures

  • Informing healthcare professionals

The disease

The hepatitis C virus (HCV) is one of the five viruses (A, B, C, D, and E) responsible for viral hepatitis. It was identified in 1989 as the causative agent of most cases of hepatitis previously referred to as “non-A, non-B hepatitis.”

Acute hepatitis C virus infection occurs after an...

Learn more

What We Do

In the general population of mainland France in 2016, approximately 133,000 people had chronic hepatitis C (the virus was present in their blood), of whom 26,000 (19%) were unaware of their infection. HCV screening and prompt initiation of treatment are therefore major challenges in the effort...

Learn more

Data

The hepatitis C surveillance system established by Santé publique France makes it possible to track epidemiological trends for this infection.

Prevalence of Hepatitis C

Monitoring of Hepatitis C Screening and Diagnostic Activities

Publications

Here you will find the latest scientific publications related to the studies and research conducted by Santé publique France.

2 publications